Contact Us

BioMARC of Colorado State University Awarded Contract to Support HIV Vaccine Production

Fort Collins, CO.  January 06, 2015 —  

Biopharmaceutical Manufacturing and Academic Resource Center (BioMARC) of Colorado State University (CSU), was recently awarded a new contract to support future manufacturing of an HIV vaccine.  This is the first of four additional planned contracts that support the development and manufacturing of a Phase II product.  The sponsor is un-named for confidentiality reasons.

“HIV prevention and treatments continue to capture worldwide attention and are significant priorities within the United States.  CSU-BioMARC is very proud to support the development of this HIV Vaccine through our sponsor.  The goal is to have a tremendous global impact with regard to the prevention of HIV infections” as stated by Dr. Pierro, Director of BioMARC.  The CDC reports that approximately 50,000 people in the United States are infected with HIV each year.  In 2013, 2.1 million new cases of HIV were reported worldwide.

 This is the third award to BioMARC from this Sponsor and follows the successful completion of an earlier process development contract that was awarded in 2012.  “This award is a clear indication of the level of confidence sponsors have in the way we manage and complete the work expected of us”, Pierro said. 

ABOUT CSU/BioMARC, 

BioMARC is a nonprofit Contract Manufacturing Service Unit owned and operated by CSU created to produce biopharmaceutical products for non-clinical, clinical, and commercial use under Biosafety Level 3 (BSL-3) and BSL-2 containment and Select Agent (SA) biosecurity conditions.  In addition to manufacturing and testing services, BioMARC offers product and process development services, which includes the creation of development programs focused on implementation of cGMP regulations and scalability issues. 

BioMARC has expertise in developing and optimizing product manufacturing processes and related tests for therapeutic, vaccines, and diagnostic products intended for use in humans.  BioMARC specializes in high containment cGMP manufacturing of biologics from preclinical stages through phase I-III and commercial production.

Please visit us at www.biomarc.colostate.edu for more information.

CONTACT INFORMATION
Dennis Pierro, PhD                                                            
Director                                                                             
dennis.pierro@colostate.edu                                              
(970) 491-8954                                                                   

Patrick Berner                                                         
Manager, Business Development
patrick.berner@clostate.edu
(970) 492-4353

 

 

Contact Information

Dennis Pierro, PhD                                                     
Director                                                                             
dennis.pierro@colostate.edu
(970) 491-8954
        
Background